Share on StockTwits

Omnicare (NYSE:OCR) Director Amy Wallman unloaded 5,672 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $63.84, for a total value of $362,100.48. Following the transaction, the director now directly owns 36,805 shares of the company’s stock, valued at approximately $2,349,631. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

OCR has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Omnicare in a research note on Thursday, July 24th. They now have a $73.00 price target on the stock, up previously from $68.00. Separately, analysts at Barclays initiated coverage on shares of Omnicare in a research note on Thursday, July 17th. They set an “equal weight” rating on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Omnicare in a research note on Friday, June 20th. They now have a $73.00 price target on the stock, up previously from $69.00. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Omnicare presently has an average rating of “Buy” and a consensus target price of $68.17.

Omnicare (NYSE:OCR) traded down 0.64% on Friday, hitting $63.52. 688,755 shares of the company’s stock traded hands. Omnicare has a one year low of $52.26 and a one year high of $67.49. The stock has a 50-day moving average of $63. and a 200-day moving average of $61.95. The company’s market cap is $6.216 billion.

Omnicare (NYSE:OCR) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $0.91 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.90 by $0.01. The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company posted $0.90 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Analysts expect that Omnicare will post $3.69 EPS for the current fiscal year.

Omnicare, Inc (NYSE:OCR) is a healthcare services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.